Richard Hughen, MBA
Richard Hughen’s thirty years of professional life science experience spans three Fortune 500 and four start-up companies with two successful exits to date. He is currently CEO of Linshom, a start-up developing a novel predictive continuous respiratory monitoring device.
Ric was an investor and member of the executive team that built start-up CSA Medical, from a technology license (Navy) through product development, animal trials, clinical trials, five FDA clearances, CE mark, three rounds of funding ($50M), commercial growth and a 2019 sale to Steris. Ric was Managing Director of a life science-focused e-learning start-up, LearnWare, which was successfully built and sold to a private equity fund.
He is currently an Entrepreneur in Residence for Johns Hopkins Tech Ventures and University of Maryland Ventures and on the strategic advisory board for George Mason University’s Bioengineering program. Ric’s background crosses diverse clinical fronts including interventional pulmonology, thoracic surgery, interventional cardiology, gastroenterology, ENT, oncology, orthopedics, gynecology, wound care, molecular diagnostics, imaging, and health-IT. He is the founder of Life Science Planning, a strategic consultancy for life science companies with a focus on fast-paced start-up, early-stage, and emerging growth companies.
Earlier in his career, Ric led various senior management, marketing, training, and sales teams for Johnson & Johnson, BD, Abbott, and Cordis. Ric holds MBA and BS degrees from The Pennsylvania State University. When not working, he is typically outside training for triathlon competitions.